7-[18F]Fluoro-8-azaisatoic Anhydrides: Versatile Prosthetic Groups for the Preparation of PET Tracers
暂无分享,去创建一个
H. Endepols | B. Neumaier | F. Neumaier | B. Zlatopolskiy | E. Urusova | S. Humpert | B. Gröner | Michael Willmann | Lisa Donnerstag | M. Willmann
[1] B. Neumaier,et al. Validation of analytical HPLC with post-column injection as a method for rapid and precise quantification of radiochemical yields. , 2023, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[2] M. Perkins,et al. Reaction of [18F]Fluoride at Heteroatoms and Metals for Imaging of Peptides and Proteins by Positron Emission Tomography , 2021, Frontiers in Chemistry.
[3] H. Endepols,et al. Rapid 18F-labeling via Pd-catalyzed S-arylation in aqueous medium. , 2021, Chemical communications.
[4] Allen F. Brooks,et al. On the consensus nomenclature rules for radiopharmaceutical chemistry - Reconsideration of radiochemical conversion. , 2020, Nuclear medicine and biology.
[5] M. Lam,et al. PSMA PET/CT in primary prostate cancer diagnostics: an overview of the literature , 2020, Tijdschrift voor Urologie.
[6] H. G. van der Poel,et al. Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study , 2020, BMC Cancer.
[7] C. Kim,et al. On-demand radiosynthesis of N-succinimidyl-4-[18F]fluorobenzoate ([18F]SFB) on an electrowetting-on-dielectric microfluidic chip for 18F-labeling of protein , 2019, RSC advances.
[8] A. Drzezga,et al. Biodistribution and radiation dosimetry of [18F]-JK-PSMA-7 as a novel prostate-specific membrane antigen-specific ligand for PET/CT imaging of prostate cancer , 2019, EJNMMI Research.
[9] F. Mottaghy,et al. Peripheral ganglia in healthy rats as target structures for the evaluation of PSMA imaging agents , 2019, BMC Cancer.
[10] A. Drzezga,et al. Discovery of 18F-JK-PSMA-7, a PET Probe for the Detection of Small PSMA-Positive Lesions , 2018, The Journal of Nuclear Medicine.
[11] P. Choyke,et al. Rapid synthesis of maleimide functionalized fluorine-18 labeled prosthetic group using "radio-fluorination on the Sep-Pak" method. , 2018, Journal of labelled compounds & radiopharmaceuticals.
[12] R. Mach,et al. Consensus nomenclature rules for radiopharmaceutical chemistry - Setting the record straight. , 2017, Nuclear medicine and biology.
[13] Steven H. Liang,et al. 18 F-Labeling of Sensitive Biomolecules for Positron Emission Tomography. , 2017, Chemistry.
[14] A. Windhorst,et al. Fluorine-18 labelled building blocks for PET tracer synthesis. , 2017, Chemical Society reviews.
[15] K. Rittinger,et al. Determination of the pKa of the N-terminal amino group of ubiquitin by NMR , 2017, Scientific Reports.
[16] P. Choyke,et al. Facile room temperature synthesis of fluorine-18 labeled fluoronicotinic acid-2,3,5,6-tetrafluorophenyl ester without azeotropic drying of fluorine-18. , 2016, Nuclear medicine and biology.
[17] B. Hadaschik,et al. F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients , 2016, European Journal of Nuclear Medicine and Molecular Imaging.
[18] B. Neumaier,et al. Seyferth-Gilbert homologation as a route to 18F-labeled building blocks: Preparation of radiofluor-inated phenylacetylenes and their application in PET chemistry , 2016 .
[19] Xiaoyuan Chen,et al. Fluorine-18 Radiochemistry, Labeling Strategies and Synthetic Routes , 2014, Bioconjugate chemistry.
[20] B. Neumaier,et al. Neither azeotropic drying, nor base nor other additives: a minimalist approach to (18)F-labeling. , 2014, Organic & biomolecular chemistry.
[21] T. Holland-Letz,et al. Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer , 2013, European Journal of Nuclear Medicine and Molecular Imaging.
[22] U. Haberkorn,et al. [68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[23] M. Pomper,et al. 2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer , 2011, Clinical Cancer Research.
[24] F. Mottaghy,et al. New molecular markers for prostate tumor imaging: a study on 2-methylene substituted fatty acids as new AMACR inhibitors. , 2011, Chemistry.
[25] A. Scott,et al. A simplified protocol for the automated production of succinimidyl 4‐[18F]fluorobenzoate on an IBA Synthera module , 2011 .
[26] S. Reske,et al. Radiosynthesis of a new PSMA targeting ligand ([18F]FPy-DUPA-Pep). , 2011, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[27] M. Finn,et al. Tailored ligand acceleration of the Cu-catalyzed azide-alkyne cycloaddition reaction: practical and mechanistic implications. , 2010, Journal of the American Chemical Society.
[28] C.伯恩哈特,et al. Nicotinamide derivatives, preparation thereof, and therapeutic use thereof as anticancer drugs , 2010 .
[29] A. Cuthbertson,et al. One step radiosynthesis of 6-[(18)F]fluoronicotinic acid 2,3,5,6-tetrafluorophenyl ester ([(18)F]F-Py-TFP): a new prosthetic group for efficient labeling of biomolecules with fluorine-18. , 2010, Journal of medicinal chemistry.
[30] S. Luthra,et al. Two-step radiosynthesis of [18F]N-succinimidyl-4-fluorobenzoate ([18F]SFB) , 2009 .
[31] A. Kozikowski,et al. A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer. , 2009, Journal of medicinal chemistry.
[32] Pius August Schubiger,et al. Molecular imaging with PET. , 2008, Chemical reviews.
[33] M. Zalutsky,et al. Synthesis of N-succinimidyl 4-[18F]fluorobenzoate, an agent for labeling proteins and peptides with 18F , 2006, Nature Protocols.
[34] W. Heston,et al. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer , 2004, Journal of cellular biochemistry.
[35] R. Leahy,et al. High-resolution 3D Bayesian image reconstruction using the microPET small-animal scanner. , 1998, Physics in medicine and biology.
[36] M. Zalutsky,et al. Fluorine-18-labeled [Nle4,d-Phe7]-α-MSH, an α-melanocyte stimulating hormone analogue , 1997 .
[37] M. Zalutsky,et al. Fluorine-18 labeled chemotactic peptides: a potential approach for the PET imaging of bacterial infection. , 1995, Nuclear medicine and biology.
[38] M. Vaultier,et al. Aliphatic amino azides as key building blocks for efficient polyamine syntheses , 1993 .
[39] D. Bigner,et al. Fluorine-18-labeled monoclonal antibody fragments: a potential approach for combining radioimmunoscintigraphy and positron emission tomography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[40] M. Hursthouse,et al. Polyfluorinated heterocyclic compounds. Part 29[1]. The synthesis of 4,5,6,7,8-pentafluoro-2H-cyclohepta[b]furan-2-one and its reaction with sodium methoxide. , 1991 .
[41] W. Jencks,et al. Concerted bimolecular substitution reactions of acetal derivatives of propionaldehyde and benzaldehyde , 1989 .
[42] G. L. Watkins,et al. Aryltrimethylammonium trifluoromethanesulfonates as precursors to aryl [18F]fluorides: Improved synthesis of [18F]GBR‐13119 , 1989 .
[43] L. Shchegoleva,et al. Polyfluorinated heterocyclic compounds , 1970 .
[44] H. Hall,et al. Correlation of the Base Strengths of Amines1 , 1957 .
[45] US 20090082426A,et al. PREPARATION THEREOF AND THERAPEUTIC USE THEREOF , 2017 .
[46] E. Dubinsky,et al. Reaction to , 2007 .